New Insight into cervical cancer development: turning it up a notch

August 31, 2002

A collaboration of scientists from Harvard Medical School and Brigham and Women's Hospital have uncovered a key genetic event in the progression of malignant cervical cancer -- and a potential new therapeutic target.

Dr. G. Paolo Dotto and colleagues have found that the decreased expression of a single gene, called Notch1, is instrumental in the late stages of human papilloma virus-induced cervical cancer. The report is published in the September 1 issue of Genes & Development.

Human papilloma virus (HPV) is the most prevalent sexually transmitted infection in the world, and HPV infection is associated with the majority of the 400,000 new cervical cancer cases reported annually. Previous genetic studies have, to some degree, elucidated the molecular mechanism of HPV-induced cervical carcinogenesis: The HPV genome encodes two viral proteins, E6 and E7, which interfere with two of the infected cell's primary tumor suppressor pathways (p53 and Rb). However, it is thought that while basal levels of E6/7 expression are necessary for HPV-induced cervical tumorigenesis, other genetic changes are needed to fully transform a normal cervical cell into a malignant one.

Dr. Dotto and colleagues have identified one such change.

Dr. Dotto and colleagues have discovered that the down-regulation of a cell signaling molecule, called Notch1, in HPV-infected cervical cells allows for the increased expression of E6 and E7, which, in turn, promote malignant cervical cell transformation. The researchers found that in low-grade HPV-positive cervical lesions, Notch1 is expressed at an adequate level to suppress E6 and E7, and thereby protects the cell against HPV-induced transformation. However, in high-grade HPV-positive cervical lesions, Notch1 expression is markedly decreased, relieving the suppression of E6 and E7 activity, and creating the correct genetic milieu for malignant cell transformation.

The researchers conclude that the reduced expression of Notch1 in HPV-infected cervical cells is an important step in malignant cervical cancer development. This finding sheds new light on the role of Notch signaling in tumorigenesis, as previous research found that the activation of Notch promotes tumor development. Dr. Dotto explains that "The main conclusion that can be drawn from our findings is that the positive or negative role of the Notch pathway in tumor development is likely to be highly context-dependent. Therefore, the potential therapeutic applications of agents that suppress Notch signaling need to be carefully evaluated, as they could have the opposite effect of what was actually intended."
-end-


Cold Spring Harbor Laboratory

Related Hpv Articles from Brightsurf:

Safety of HPV vaccines in males
A new analysis published in the British Journal of Clinical Pharmacology shows that HPV vaccines are safe and well tolerated in the male population, and the side effects that may occur after immunization are similar in both sexes.

HPV strains may impact cervical cancer prognosis
An analysis of cervical cancers in Ugandan women has uncovered significant genomic differences between tumours caused by different strains of human papillomavirus (HPV), signifying HPV type may impact cervical cancer characteristics and prognosis.

HPV infections can be eliminated if both boys and girls are vaccinated
The human papillomavirus (HPV) causes, amongst other diseases, cancer of the cervix and oropharynx.

Addressing HPV vaccination concerns
Research from the Harvard Pilgrim Health Care Institute finds a promising avenue for addressing vaccine hesitancy around HPV vaccine.

Young men unaware of risks of HPV infection and need for HPV vaccination
Young sexual minority men -- including those who are gay, bisexual, queer or straight-identified men who have sex with men -- do not fully understand their risk for human papillomavirus (HPV) due to a lack of information from health care providers, according to Rutgers researchers.

Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.

Trying to help parents decide to vaccinate kids against HPV? Consider storytelling
Health campaigns on social media aimed at increasing human papillomavirus (HPV) vaccination may see greater success, according to Drexel University researchers, if they inject a narrative into information-based posts.

Religion associated with HPV vaccination rate for college women
A survey of female college students finds 25% had not been vaccinated for HPV and religion may be a contributing factor.

One dose of HPV vaccine may be enough, Australian research finds
One dose of human papillomavirus (HPV) vaccine has comparable effectiveness to 2 or 3 doses for preventing cervical pre-cancer, according to a new study.

The Lancet: HPV vaccination programmes have substantial impact in reducing HPV infections and precancerous cervical lesions
The new study is the first to show pooled estimates of population-level impact of HPV vaccination on CIN2+ from several countries, the benefit of vaccinating more than one age group, along with substantial herd effects in countries achieving high vaccination coverage.

Read More: Hpv News and Hpv Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.